Why you should consider Portugal for its private health care system - compared to the U.S.

Portugal’s private health system is generally much cheaper and more predictable than the American private system, especially for people with chronic diseases. In the U.S., private insurance can still leave patients facing large premiums, deductibles, and out-of-pocket bills, while in Portugal private care is usually used as a supplement to a lower-cost public system, keeping total costs far lower overall.

System structure

Portugal has a dual model: a public National Health Service for residents and a private sector that offers faster access, shorter waits, and more choice. Private insurance in Portugal is usually optional and comparatively affordable, while in the U.S. private insurance is the main gateway to care for most people and is often tied to employers or bought individually.

The result is a very different financial experience. In Portugal, private care may be used for convenience; in the U.S., private coverage is often essential for avoiding catastrophic bills.

Typical private-care costs

Private consultations in Portugal are relatively modest by international standards. Examples in the sources include about €50 for a general practitioner visit, about €90 for a specialist, and private insurance starting around €30 per month for a young person, rising to about €300 per month for a couple in their 60s with stronger coverage.

By contrast, U.S. private care is much more expensive. A U.S. private hospital stay can start around $3,000 per day and rise to $15,000 or more, while even a routine doctor visit can be far more expensive than in Portugal.

Chronic disease costs

Chronic disease is where the contrast becomes most visible. In Portugal, insurers often exclude pre-existing conditions or apply waiting periods, but public care can heavily subsidize ongoing treatment and medication; one source notes that chronic-condition medications are often subsidized anywhere from 10% to 90%, and can be free in serious cases.

In the U.S., chronic disease care can generate high annual expenses even for insured patients. The American Diabetes Association notes that extra costs for an insured person with diabetes can exceed $4,800 per year, and a more recent KFF report shows one patient paying $125 monthly for insulin plus $150 per endocrinology visit and $111 for labs before each visit. A peer-reviewed study also found substantial out-of-pocket burden for U.S. patients with diabetes, with out-of-pocket costs in the thousands per year and much higher total costs of care.

What this means in practice

For a healthy person, Portuguese private care often means paying a manageable monthly premium and modest visit fees for quick access. For someone with a chronic disease, Portugal’s public system can absorb much of the long-term burden, while private insurance may not fully cover pre-existing conditions unless the policy is structured for that.

In the U.S., chronic illness often remains expensive even with insurance because costs are split across premiums, deductibles, copays, drugs, and specialist visits. That makes the American private system more flexible in access but far less predictable financially.

Conclusion

The Portuguese private health system is cheaper, simpler, and less financially risky than the American private system, especially for chronic disease management. The U.S. system can offer broader coverage options and more high-tech specialization, but it does so at much higher cost and with far greater exposure to out-of-pocket spending.

At Tellefsen Consulting we support expats who are considering to make the move to Portugal including insurance and health insurance brokerage. For more information please contact us at contact@tellefsen-consulting.com